Dunhill Financial’s GSK GSK Stock Holding History

Dunhill Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76K	Buy	1,449 +626	+76%	+$33.1K	0.02%	264
2026 Q1	$45.4K	Hold	823	–	–	0.01%	327
2025 Q4	$40.4K	Hold	823	–	–	0.01%	305
2025 Q3	$35.5K	Hold	823	–	–	0.01%	295
2025 Q2	$31.6K	Hold	823	–	–	0.01%	280
2025 Q1	$31.9K	Hold	823	–	–	0.01%	239
2024 Q4	$27.8K	Hold	823	–	–	0.01%	240
2024 Q3	$33.6K	Sell	823 -11,473	-93%	-$469K	0.02%	205
2024 Q2	$473K	Buy	+12,296	New	+$517K	0.29%	34

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dunhill Financial's GSK Position: Q2 2026 in Review

Dunhill Financial increased its GSK (GSK) stake by 76% in Q2 2026, buying an estimated $33.1K and bringing the position to 1,449 shares worth $76K. The position accounts for 0.02% of the portfolio, ranked #264.

Dunhill Financial first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $473K in Q2 2024. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Dunhill Financial held 1,449 shares of GSK worth $76K as of Q2 2026.
Dunhill Financial bought 626 GSK shares in Q2 2026, an estimated $33.1K.
GSK made up 0.02% of Dunhill Financial's portfolio in Q2 2026, its #264 holding.
Dunhill Financial first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
Dunhill Financial's GSK position peaked at $473K in Q2 2024.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.